IFC-100

A fluorescence-based immunoassay platform from the POCT series designed for rapid diagnostic testing. The SF-100 platform enables high-sensitivity and high-precision immunofluorescence detection for various clinical analytes and sample types.

Immunofluorescence-based test kits utilizing quantum dot technology for enhanced sensitivity and photostability. Provide qualitative and quantitative detection of various analytes in clinical samples.

A portable single-channel fluorescence immunoassay analyzing system equipped with a built-in battery for point-of-care testing. The compact handheld design enables diagnostic testing in various clinical settings.

A platform for immune diagnosis devices based on Quantum Dot fluorescence measurement mode technology. It includes Quantum Dot labeled detection kits for enhanced sensitivity, precise analysis, and multiplex analysis capabilities. The platform offers both Gold Type and Quantum Dot Type kits with sensitivity down to ng/ml levels and 500-1,000 fold higher accuracy compared to gold standard detection methods.

A single-channel fluorescence immunoassay system designed for ease of use with a 3.5-inch screen and intuitive user interface. The analyzer is compact and suitable for point-of-care diagnostic applications.

Fluorescence immunoassay kits utilizing quantum dots technology. Offer superior photostability and brightness compared to conventional fluorescent markers for immunodiagnostic applications.

A quantum dot-network based fluorescence measurement system developed for rapid on-site COVID-19 testing, enabling faster and more accurate measurements through a smart system architecture.

CE-marked fluorescence immunoassay (FIA) analyzer for quantitative point-of-care testing. The MF-T1000 platform delivers rapid diagnostic results with 92.9%+ sensitivity, supporting respiratory combo tests (4-in-1/9-in-1 configurations) for clinical laboratories and healthcare facilities.

Fluorescence immunochromatography analyzer for rapid point-of-care testing (POCT) and clinical diagnostics. Detects biomarkers and analytes using fluorescence-based immunoassay technology for disease screening and monitoring. Integrates with chronic disease management systems for automated result processing and data management.

The DCR1000 is a point-of-care diagnostic test system utilizing agglutination, immuno-dot, immuno-chromatographic, and immuno-filtration techniques for rapid infectious disease detection. Delivering results in 3-30 minutes with minimal equipment requirements, it enables same-day clinical decision-making in resource-limited settings. Room-temperature stability and low-sample-volume design make it economical for low-throughput laboratory environments.

Portable fluorescence immunoassay system for rapid point-of-care diagnostic testing. Enables detection and quantification of biomarkers in clinical specimens through fluorescence-based immunoassay methodology. Designed for laboratory and clinical use with portable form factor for decentralized testing applications.

Quantum dot fluorescence-based platform for in vitro diagnostic applications. Supports development of various immunological assays with enhanced optical properties and batch consistency.